IMDX
NASDAQ · Biotechnology
Insight Molecular Diagnostic
$4.05
+0.34 (+9.16%)
Open$3.79
Previous Close$3.71
Day High$4.20
Day Low$3.76
52W High$8.51
52W Low$2.33
Volume—
Avg Volume128.0K
Market Cap153.70M
P/E Ratio—
EPS$-1.48
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+329.9% upside
Current
$4.05
$4.05
Target
$17.41
$17.41
$14.05
$17.41 avg
$26.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.24M | 2.62M | 22.03M |
| Net Income | -52,439,794 | -29,196,297 | 4.29M |
| Profit Margin | -1,238.5% | -1,176.6% | 19.5% |
| EBITDA | -51,179,635 | -30,077,731 | 9.08M |
| Free Cash Flow | — | — | 3.08M |
| Rev Growth | +61.7% | +61.7% | +9.7% |
| Debt/Equity | — | — | 1.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |